Drugs / ferrous(II)-glycine-sulphate complex
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01425463 | Mar 2011 → Oct 2013 | iron deficiency anemia | Sanol GmbH | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03347513 Background | Nov 2017 → Mar 2019 | Helicobacter pylori infectious disease, iron deficiency anemia, pregnancy disorder | Kasr El Aini Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ferrous(II)-glycine-sulphate complex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03347513 ↗ |
| Route | Oral | “Administered orally with water.” NCT01425463 ↗ |